6. References:
Thanks to improved treatment strategies, patients with cancer are surviving longer and undergoing more cancer treatments. In the future, this will increase the incidence of VTE for cancer patients:
1. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood Sep 5;122(10):
2. Lyman GH. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis. Cancer 2011;117:1334–1349.
3. Cronin-Fenton DP, Søndergaard F, Pedersen LA, et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006. British journal of cancer Sep;103(7):947.
4. Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med Jan;119(1):60-8.
5. Cohen AT, Katholing A, Rietbrock S, Bamber L, Martinez C. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. Thrombosis and haemostasis Jan;117(01):57-65.
Risk of VTE is higher in the first 3 months of cancer after diagnosis:
1. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood Sep 5;122(10):
2. Lyman GH. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis. Cancer 2011;117:
VTE risk is 20 times higher for distant metastatic disease compared to localised cancer:
1. Fuentes HE, Tafur AJ, Caprini JA. Cancer-associated thrombosis. Dis Mon 2016;62(5):
2. Cronin-Fenton DP, Søndergaard F, Pedersen LA, et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006. British journal of cancer Sep;103(7):947.
VTE incidence by cancer type:
1. Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med Jan;119(1):60-8
Incidence of a first venous thromboembolic event was highest in the elderly population:
1. Cohen AT, Katholing A, Rietbrock S, et al. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. Thrombosis and haemostasis Jan;117(01):57-65.